|
IIb |
|
Terminated |
|
Merck, HIV Vaccine Trials Network (HVTN) |
|
|
|
MRKAd5 HIV-1 gag/pol/nef |
|
|
|
?Adults at High Risk of HIV-1 Infection |
|
|
|
RandD/trials/Lists/ClinicalTrialsList |
|
|
|
|
|
|
|
|
|
|
|
9/1/2009 |
|
|
|
|
|
Ad5 vectored with gag gene from the HIV-1 strain CAM-1, the pol gene from HIV-1 strain IIIB and the nef gene from HIV-1 strain JR-FL |
|
|
|
?1.5x10^10 ad-vg/dose at Day 1, Week 4, and Week 26
|